Schedule 13G ownership disclosure

Palisade Bio, Inc.

Common Stock, par value $0.01 per share · CUSIP: 696389402

Event date: 2025-10-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 7,308,580.00 · Class: 7.6%

  • Squadron Capital Management LLC

    Shares: 8,250,000.00 · Class: 8.5%

  • Matthew Sesterhenn

    Shares: 8,250,000.00 · Class: 8.5%

  • William Blank

    Shares: 8,250,000.00 · Class: 8.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-25-000007
Form type
SCHEDULE 13G
Filer
PALISADE BIO, INC.
CIK
CIK 1357459
Filed
Oct 08, 2025
Reporting period
Oct 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub